BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 38260737)

  • 1. Extracellular vesicles and exosome-like nanovesicles as pioneering oral drug delivery systems.
    Mondal J; Pillarisetti S; Junnuthula V; Surwase SS; Hwang SR; Park IK; Lee YK
    Front Bioeng Biotechnol; 2023; 11():1307878. PubMed ID: 38260737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.
    Li DF; Yang MF; Xu J; Xu HM; Zhu MZ; Liang YJ; Zhang Y; Tian CM; Nie YQ; Shi RY; Wang LS; Yao J
    Int J Nanomedicine; 2022; 17():3893-3911. PubMed ID: 36092245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.
    Dad HA; Gu TW; Zhu AQ; Huang LQ; Peng LH
    Mol Ther; 2021 Jan; 29(1):13-31. PubMed ID: 33278566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery.
    Poinsot V; Pizzinat N; Ong-Meang V
    Nanomaterials (Basel); 2024 Apr; 14(7):. PubMed ID: 38607173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Protocols for Scalable Production of High Quality Purified Small Extracellular Vesicles from Bovine Milk.
    Marsh SR; Pridham KJ; Jourdan J; Gourdie RG
    Nanotheranostics; 2021; 5(4):488-498. PubMed ID: 34367882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant Extracellular Vesicles and Nanovesicles: Focus on Secondary Metabolites, Proteins and Lipids with Perspectives on Their Potential and Sources.
    Woith E; Guerriero G; Hausman JF; Renaut J; Leclercq CC; Weise C; Legay S; Weng A; Melzig MF
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles-Oral Therapeutics of the Future.
    Cieślik M; Nazimek K; Bryniarski K
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers.
    Moloudizargari M; Asghari MH; Goel A
    Biochem Pharmacol; 2021 Oct; 192():114714. PubMed ID: 34332957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration.
    Ju Y; Hu Y; Yang P; Xie X; Fang B
    Mater Today Bio; 2023 Feb; 18():100522. PubMed ID: 36593913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicle- and Extracellular Vesicle Mimetics-Based Drug Delivery Systems: New Perspectives, Challenges, and Clinical Developments.
    Gangadaran P; Ahn BC
    Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32403320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potentiality of Plant-Derived Nanovesicles in Human Health-A Comparison with Human Exosomes and Artificial Nanoparticles.
    Logozzi M; Di Raimo R; Mizzoni D; Fais S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines.
    Kuriyama N; Yoshioka Y; Kikuchi S; Okamura A; Azuma N; Ochiya T
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities.
    Claridge B; Lozano J; Poh QH; Greening DW
    Front Cell Dev Biol; 2021; 9():734720. PubMed ID: 34616741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered Exosomes for Tumor-Targeted Drug Delivery: A Focus on Genetic and Chemical Functionalization.
    Akbari A; Nazari-Khanamiri F; Ahmadi M; Shoaran M; Rezaie J
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.
    Mondal J; Pillarisetti S; Junnuthula V; Saha M; Hwang SR; Park IK; Lee YK
    J Control Release; 2023 Jan; 353():1127-1149. PubMed ID: 36528193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant-Derived Extracellular Vesicles as Therapeutic Nanocarriers.
    Karamanidou T; Tsouknidas A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.